A solid-phase mutual inhibition assay with labeled antigen.
A widely applicable method for the determination of the epitope specificities of a large number of monoclonal antibodies (MAbs) is presented. The method is based on the solid-phase mutual inhibition assay using 96-well plates coated with the respective MAbs, competitor MAbs, biotinylated antigen, and avidin-peroxidase conjugate. Using carcinoembryonic antigen (CEA) as a model antigen, the method was applied to determine epitope specificities of anti-CEA MAbs. A constant amount of biotinylated CEA was incubated with a given MAb immobilized on wells of 96-well plates in the presence of increasing amounts of soluble competitor MAbs. The biotinylated CEA bound to the immobilized antibody was then reacted with avidin-peroxidase conjugate and the activity of the bound peroxidase was determined by using o-phenylenediamine and hydrogen peroxide. The method used alleviates the laborious procedures of labeling all antibodies to be tested and the confusion caused by differential labeling among different MAbs. It is a convenient method for mapping analysis of many MAbs if the corresponding purified antigen is available.